Opioid plaintiffs fight bid to disqualify U.S. judge before trial

By Nate Raymond (Reuters) - Lawyers for cities and counties suing drug companies over the opioid epidemic on Monday objected to a bid by pharmaceutical distributors and pharmacies to disqualify the federal judge overseeing the cases, saying it had no basis and came too late. The plaintiffs' lawyers moved swiftly to fight the request companies including AmerisourceBergen Corp , Cardinal Health Inc and McKesson Corp had made on Saturday for U.S.

Reuters September 17, 2019 02:06:06 IST
Opioid plaintiffs fight bid to disqualify U.S. judge before trial

Opioid plaintiffs fight bid to disqualify US judge before trial

By Nate Raymond

(Reuters) - Lawyers for cities and counties suing drug companies over the opioid epidemic on Monday objected to a bid by pharmaceutical distributors and pharmacies to disqualify the federal judge overseeing the cases, saying it had no basis and came too late.

The plaintiffs' lawyers moved swiftly to fight the request companies including AmerisourceBergen Corp , Cardinal Health Inc and McKesson Corp had made on Saturday for U.S. District Judge Dan Polster in Cleveland, Ohio, to step aside from the litigation.

In Monday's brief, lawyers for the plaintiffs said the defendants had waived their ability to seek Polster's recusal, noting they were relying on statements he made more than a year ago to belatedly seek his disqualification.

"If these Defendants really thought recusal was necessary, they were required to raise the issue sooner - much sooner," the plaintiffs' lawyers wrote.

More than 2,500 lawsuits by state and local governments are pending nationally, accusing drug manufacturers of deceptively marketing opioids in ways that downplayed their risks, and drug distributors of failing to detect and halt suspicious orders.

The companies deny wrongdoing. Nearly 2,100 of the lawsuits are before Polster, while others are in state courts.

The companies had argued in Saturday's motion that Polster, who has long pushed for a settlement that could "do something meaningful to abate this crisis," had made a series of public statements since 2018 that could cause a reasonable person to question his impartiality.

They said those statements, made in court hearings and media interviews, raised the prospect that he had improperly prejudged their liability ahead of the first trial on Oct. 21 involving two Ohio counties seeking $8 billion.

In Monday's brief, the plaintiffs' lawyers said the companies did not take action when Polster made those comments and actively participated in court-overseen settlement talks without objection.

Polster "has at no time expressed improper or biased views about the liability of any defendant, much less views based on extra-judicial sources," the lawyers wrote.

The companies who joined Saturday's motion also include CVS Health Corp and Walmart Inc . The defendants did not respond to requests for comment.

Opioids were involved in 400,000 overdose deaths from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention.

OxyContin maker Purdue Pharma, one of the lead defendants, filed for bankruptcy protection on Monday after reaching a tentative deal to resolve claims in the federal litigation and by 24 U.S. states.

(Reporting by Nate Raymond in Boston; Editing by Bill Berkrot)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Intel seeks $10 billion in subsidies for European chip plant
News & Analysis

Intel seeks $10 billion in subsidies for European chip plant

By Douglas Busvine BRUSSELS/BERLIN (Reuters) -Intel wants 8 billion euros ($9.7 billion) in public subsidies towards building a semiconductor factory in Europe, its CEO was cited as saying on Friday, as the region seeks to reduce its reliance on imports amid a shortage of supplies. The pitch is the first time Pat Gelsinger has publicly put a figure on how much state aid he would want, as Intel pursues a multibillion-dollar drive to take on Asian rivals in contract manufacturing. "What we're asking from both the U.S

China's Ximalaya, Qiniu file for U.S. IPOs
News & Analysis

China's Ximalaya, Qiniu file for U.S. IPOs

(Reuters) -Ximalaya, backed by China's Tencent Holdings, filed for an initial public offering (IPO) in the United States on Friday, cashing in on growing demand as more people tune in to podcasts while staying at home during the pandemic. China's Qiniu Ltd, a cloud-based platform-as-a-service provider backed by Alibaba Group Holding Ltd, also filed paperwork for a U.S. IPO

Donerail pushes gaming headset maker Turtle Beach to explore a sale - sources
News & Analysis

Donerail pushes gaming headset maker Turtle Beach to explore a sale - sources

By Greg Roumeliotis (Reuters) - Donerail Group, an investment firm led by former activist hedge fund Starboard Value LP executive Will Wyatt, has amassed a stake in Turtle Beach Corp and is pushing the maker of gaming headsets to explore a sale, people familiar with the matter said on Friday. The move represents a bet that Turtle Beach could attract acquisition interest from peers such as Corsair Gaming Inc and GN Store Nord A/S, as the video game market continues to benefit from people looking for entertainment options at home during the COVID-19 pandemic